In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum. Related Products of 10034-20-5, Related Products of 10034-20-5, C14H22ClNO9. A document type is Patent, introducing its new discovery.
The present disclosure provides a compound of Formula (I) or any pharmaceutically acceptable salt thereof for use in treating a microbial infection in a subject, a method for preparing the same, and a pharmaceutical composition thereof: (I) wherein R1 may include hydrogen; alkyl; cycloalkyl; alkenyl; cycloalkenyl; alkynyl; aryl; or heteroaryl; R2, R3, R4 may independently include hydrogen; alkyl; cycloalkyl; alkoxy; aryloxy; heteroaryloxy; halogen; hydroxyl; cyano; or heteroaryl; R5, R6, R7, R8 may include free hydroxy groups; fully acylated hydroxy groups; or partially acylated hydroxy groups having the group R9-(C=O)-; and wherein R9 may include alkyl; substituted or unsubstituted aryl; or arylalkyl.
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Related Products of 10034-20-5. This is the end of this tutorial post, and I hope it has helped your research about 10034-20-5
Reference：
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics